- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有257家主力机构披露2025-06-30报告期持股数据，持仓量总计9.74亿股，占流通A股49.71%
- 波段诊断：
-
技术面诊股
诊断结果：6.2技术面打败了72%的股票
技术面评分前10的股票
近期的平均成本为8.84元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为8.84元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.84","date":1765358046,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，跑赢行业平均水平。
[{"date":"2025.12.11","stock":"1.03","trade":"-0.99","ind":"-0.70"},{"date":"2025.12.10","stock":"0.23","trade":"0.09","ind":"-0.23"},{"date":"2025.12.09","stock":"-0.46","trade":"-1.60","ind":"-0.37"},{"date":"2025.12.08","stock":"-0.57","trade":"-0.11","ind":"0.54"},{"date":"2025.12.05","stock":"0.57","trade":"0.56","ind":"0.70"},{"date":"2025.12.04","stock":"-0.68","trade":"-0.56","ind":"-0.06"},{"date":"2025.12.03","stock":"0.92","trade":"-0.02","ind":"-0.51"},{"date":"2025.12.02","stock":"-0.23","trade":"-1.62","ind":"-0.42"},{"date":"2025.12.01","stock":"-0.34","trade":"0.00","ind":"0.65"},{"date":"2025.11.28","stock":"0.34","trade":"0.19","ind":"0.34"},{"date":"2025.11.27","stock":"-0.23","trade":"-0.26","ind":"0.29"},{"date":"2025.11.26","stock":"2.09","trade":"0.65","ind":"-0.15"},{"date":"2025.11.25","stock":"0.47","trade":"1.51","ind":"0.87"},{"date":"2025.11.24","stock":"0.35","trade":"1.45","ind":"0.05"},{"date":"2025.11.21","stock":"-3.18","trade":"-3.82","ind":"-2.45"},{"date":"2025.11.20","stock":"-0.11","trade":"-0.92","ind":"-0.40"},{"date":"2025.11.19","stock":"-0.79","trade":"-1.90","ind":"0.18"},{"date":"2025.11.18","stock":"-1.44","trade":"-0.92","ind":"-0.81"},{"date":"2025.11.17","stock":"-2.06","trade":"-2.18","ind":"-0.46"},{"date":"2025.11.14","stock":"-0.32","trade":"0.63","ind":"-0.97"},{"date":"2025.11.13","stock":"0.00","trade":"1.09","ind":"0.73"}]
通化东宝,上证指数,生物制品指数
压力支撑
该股压力位为8.80元，支撑位为8.69元。
[{"text":"\u538b\u529b\u4f4d","value":"8.80","date":1765382400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.69","date":1765382400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.5资金面打败了68%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月11日 20:38
| 机构今日流向(万元) | -1279.66 | 机构5日流向(万元) | -5165.19 |
| 机构10日流向(万元) | -9641.33 | 机构20日流向(万元) | -21388.68 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1254.19万股，其中基金净减仓67家，主力净增仓62家，请投资者中长期谨慎为宜。
截止2025-06-30，共257家主力机构（基金252家，一般法人4家，QFII1家），持仓量总计97358.09万股，占流通A股49.71%
其中，基金持仓与2024-12-31相比：
增仓：29家 ，增持 458.14万股
减仓：96家 ，减持 2324.48万股
新出现在主力名单中：117家 ，持有2444.28万股
从主力名单中消失：55家 ，原持有915.52万股
其中，基金持仓与2024-12-31相比：
增仓：29家 ，增持 458.14万股
减仓：96家 ，减持 2324.48万股
新出现在主力名单中：117家 ，持有2444.28万股
从主力名单中消失：55家 ，原持有915.52万股
消息面诊股
诊断结果：5.5消息面打败了63%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 首版商保创新药目录发布：阿尔茨海默病新药纳入 肿瘤
2025-12-10 - 通化东宝：12月5日获融资买入607.35万元
2025-12-06 - 中东资金再加仓！四季度爱上A股机器人公司！
2025-12-05 - 行业周报|生物制品指数跌-1.63%, 跑输上证指
2025-12-05 - 通化东宝：12月4日获融资买入787.23万元
2025-12-05 - 医药行业2026年展望：创新药+CXO产业链+医保
2025-12-04 - 通化东宝：12月1日获融资买入1584.49万元
2025-12-02 - 通化东宝：11月28日获融资买入729.47万元
2025-11-29 - 通化东宝拟推研发生产系统员工持股计划
2025-11-28 - 行业周报|生物制品指数涨3.58%, 跑赢上证指数
2025-11-28
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-29 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-03 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 高管变动 | 调整第十一届董事会审计委员会人员构... | 2025-08-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-26 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-07-15 |
| 一般消息 | 高管变动 | 个人原因 | 2025-07-04 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-07-04 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-09 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2025-04-30 |
| 利空 | 业绩预告 | 业绩预亏 | 2025-04-28 |
| 一般消息 | 高管变动 | 因公司组织架构及管理分工安排调整原... | 2025-03-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-11 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-02-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-20 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-01-04 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 3条 | 2条 | 1条 |
行业面诊股
诊断结果：5.2行业面打败了73%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.12.11","price":"-0.70","value":"-0.99"},{"date":"2025.12.10","price":"-0.23","value":"0.09"},{"date":"2025.12.09","price":"-0.37","value":"-1.60"},{"date":"2025.12.08","price":"0.54","value":"-0.11"},{"date":"2025.12.05","price":"0.70","value":"0.56"},{"date":"2025.12.04","price":"-0.06","value":"-0.56"},{"date":"2025.12.03","price":"-0.51","value":"-0.02"},{"date":"2025.12.02","price":"-0.42","value":"-1.62"},{"date":"2025.12.01","price":"0.65","value":"0.00"},{"date":"2025.11.28","price":"0.34","value":"0.19"},{"date":"2025.11.27","price":"0.29","value":"-0.26"},{"date":"2025.11.26","price":"-0.15","value":"0.65"},{"date":"2025.11.25","price":"0.87","value":"1.51"},{"date":"2025.11.24","price":"0.05","value":"1.45"},{"date":"2025.11.21","price":"-2.45","value":"-3.82"},{"date":"2025.11.20","price":"-0.40","value":"-0.92"},{"date":"2025.11.19","price":"0.18","value":"-1.90"},{"date":"2025.11.18","price":"-0.81","value":"-0.92"},{"date":"2025.11.17","price":"-0.46","value":"-2.18"},{"date":"2025.11.14","price":"-0.97","value":"0.63"},{"date":"2025.11.13","price":"0.73","value":"1.09"}]
上证指数,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 欧林生物 | 9.29% | -7.11% | 6.5分 |
| 2 | 特宝生物 | 7.82% | 2.67% | 6.7分 |
| 3 | 金迪克 | 0.17% | -13.97% | 3.6分 |
| 4 | 万泽股份 | -0.27% | 8.39% | 6.3分 |
| 5 | 荣昌生物 | -0.69% | -7.32% | 5.0分 |
| 6 | 甘李药业 | -1.00% | 4.60% | 5.9分 |
| 8 | 通化东宝 | -4.44% | 0.80% | 5.9分 |
| 10 | 诺诚健华 | -5.32% | -4.07% | 4.8分 |
| 12 | 成大生物 | -5.83% | -0.75% | 4.9分 |
| 14 | *ST四环 | -6.54% | -2.80% | 5.1分 |
| 16 | 君实生物 | -7.37% | 1.57% | 5.3分 |
| 18 | 智翔金泰 | -7.91% | 0.04% | 5.3分 |
| 20 | 我武生物 | -9.03% | -3.54% | 4.5分 |
| 22 | 康辰药业 | -9.28% | -4.54% | 5.0分 |
| 24 | 赛伦生物 | -9.63% | -1.69% | 5.0分 |
| 26 | 天坛生物 | -9.99% | -1.94% | 5.0分 |
| 28 | 智飞生物 | -10.65% | -2.91% | 4.2分 |
| 30 | ST未名 | -10.94% | -0.68% | 4.4分 |
| 32 | 昊帆生物 | -11.06% | 0.67% | 4.3分 |
| 34 | 安科生物 | -11.25% | 1.35% | 5.4分 |
| 36 | 沃森生物 | -11.69% | -2.91% | 4.2分 |
| 38 | 百奥泰 | -12.35% | -1.47% | 4.8分 |
| 40 | 康希诺 | -12.52% | -0.82% | 4.5分 |
| 42 | 百普赛斯 | -13.25% | -1.11% | 4.4分 |
| 44 | 辽宁成大 | -13.59% | -2.93% | 4.7分 |
| 46 | 艾迪药业 | -14.24% | -0.77% | 5.4分 |
| 48 | 科兴制药 | -14.42% | -0.61% | 5.6分 |
| 50 | 三生国健 | -14.67% | -2.66% | 4.9分 |
| 52 | 派林生物 | -16.30% | -6.12% | 3.9分 |
| 54 | 博晖创新 | -22.52% | -6.64% | 4.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：很强，居行业前列，两项指标的行业排名分别为 3/72 ， 29/72。
[{"date":"2025-09-30","value":"17.80","vol":"-9.78"},{"date":"2025-06-30","value":"3.48","vol":"-0.61"},{"date":"2025-03-31","value":"1.70","vol":"0.46"},{"date":"2024-12-31","value":"-0.63","vol":"-0.68"},{"date":"2024-09-30","value":"-0.97","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
17.80 | 3.48 | 1.70 | -0.63 | -0.97 |
| 行业(%) | -9.78 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"71.89","vol":"67.61"},{"date":"2025-06-30","value":"71.45","vol":"68.28"},{"date":"2025-03-31","value":"69.32","vol":"68.43"},{"date":"2024-12-31","value":"73.90","vol":"69.85"},{"date":"2024-09-30","value":"74.47","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
71.89 | 71.45 | 69.32 | 73.90 | 74.47 |
| 行业(%) | 67.61 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，居行业前列，两项指标的行业排名分别为 7/72 ， 1/72。
[{"date":"2025-09-30","value":"50.55","vol":"45.25"},{"date":"2025-06-30","value":"85.60","vol":"6902.04"},{"date":"2025-03-31","value":"10.17","vol":"6125.27"},{"date":"2024-12-31","value":"-34.66","vol":"47.35"},{"date":"2024-09-30","value":"-30.78","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
50.55 | 85.60 | 10.17 | -34.66 | -30.78 |
| 行业(%) | 45.25 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1911.35","vol":"44.80"},{"date":"2025-06-30","value":"194.48","vol":"5.44"},{"date":"2025-03-31","value":"-49.15","vol":"-8.46"},{"date":"2024-12-31","value":"-103.66","vol":"-9.81"},{"date":"2024-09-30","value":"-108.73","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
1911.35 | 194.48 | -49.15 | -103.66 | -108.73 |
| 行业(%) | 44.80 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，两项指标的行业排名分别为 16/72 ， 19/72。
[{"date":"2025-09-30","value":"0.28","vol":"0.22"},{"date":"2025-06-30","value":"0.18","vol":"0.14"},{"date":"2025-03-31","value":"0.09","vol":"0.06"},{"date":"2024-12-31","value":"0.27","vol":"0.29"},{"date":"2024-09-30","value":"0.19","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.28 | 0.18 | 0.09 | 0.27 | 0.19 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.83","vol":"0.92"},{"date":"2025-06-30","value":"0.53","vol":"0.56"},{"date":"2025-03-31","value":"0.27","vol":"0.26"},{"date":"2024-12-31","value":"0.73","vol":"1.17"},{"date":"2024-09-30","value":"0.50","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.83 | 0.53 | 0.27 | 0.73 | 0.50 |
| 行业(次) | 0.92 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"7.80","vol":"1.84"},{"date":"2025-06-30","value":"30.25","vol":"-1377.61"},{"date":"2025-03-31","value":"15.19","vol":"-46.99"},{"date":"2024-12-31","value":"41.76","vol":"-11.33"},{"date":"2024-09-30","value":"13.70","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.80 | 30.25 | 15.19 | 41.76 | 13.70 |
| 行业 | 1.84 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.97","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.77","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.97 | - | 2.77 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 35/72 ， 36/72。
[{"date":"2025-09-30","value":"4.64","vol":"6.00"},{"date":"2025-06-30","value":"1.76","vol":"6.64"},{"date":"2025-03-31","value":"2.89","vol":"7.75"},{"date":"2024-12-31","value":"3.02","vol":"6.72"},{"date":"2024-09-30","value":"4.30","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.64 | 1.76 | 2.89 | 3.02 | 4.30 |
| 行业 | 6.00 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.38","vol":"4.84"},{"date":"2025-06-30","value":"1.17","vol":"5.30"},{"date":"2025-03-31","value":"1.72","vol":"6.35"},{"date":"2024-12-31","value":"1.80","vol":"5.40"},{"date":"2024-09-30","value":"2.32","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.38 | 1.17 | 1.72 | 1.80 | 2.32 |
| 行业 | 4.84 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 36/72 ， 36/72。
[{"date":"2025-09-30","value":"12.46","vol":"28.18"},{"date":"2025-06-30","value":"21.80","vol":"26.73"},{"date":"2025-03-31","value":"13.73","vol":"26.03"},{"date":"2024-12-31","value":"13.26","vol":"25.81"},{"date":"2024-09-30","value":"9.74","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
12.46 | 21.80 | 13.73 | 13.26 | 9.74 |
| 行业(%) | 28.18 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.14","vol":"0.58"},{"date":"2025-06-30","value":"0.28","vol":"1.11"},{"date":"2025-03-31","value":"0.16","vol":"0.78"},{"date":"2024-12-31","value":"0.15","vol":"0.87"},{"date":"2024-09-30","value":"0.11","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.14 | 0.28 | 0.16 | 0.15 | 0.11 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华创证券 | 2025-11-23 | 增持 | |
| 交银国际证券 | 2025-10-31 | 增持 | |
| 华泰证券 | 2025-10-28 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"13.08","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"15.82","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.43","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.08","blueLineValue":"0.46","type":"YC"}]